2bnu
From Proteopedia
(Difference between revisions)
Line 20: | Line 20: | ||
==About this Structure== | ==About this Structure== | ||
- | 2BNU is a | + | 2BNU is a 2 chains structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2BNU OCA]. |
==Reference== | ==Reference== | ||
- | + | <ref group="xtra">PMID:15837811</ref><references group="xtra"/> | |
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
- | [[Category: Protein complex]] | ||
[[Category: Bossi, G.]] | [[Category: Bossi, G.]] | ||
[[Category: Boultier, J M.]] | [[Category: Boultier, J M.]] | ||
Line 52: | Line 51: | ||
[[Category: Transmembrane]] | [[Category: Transmembrane]] | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Feb 16 14:09:00 2009'' |
Revision as of 12:09, 16 February 2009
STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
Template:ABSTRACT PUBMED 15837811
About this Structure
2BNU is a 2 chains structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Chen JL, Stewart-Jones G, Bossi G, Lissin NM, Wooldridge L, Choi EM, Held G, Dunbar PR, Esnouf RM, Sami M, Boulter JM, Rizkallah P, Renner C, Sewell A, van der Merwe PA, Jakobsen BK, Griffiths G, Jones EY, Cerundolo V. Structural and kinetic basis for heightened immunogenicity of T cell vaccines. J Exp Med. 2005 Apr 18;201(8):1243-55. PMID:15837811 doi:10.1084/jem.20042323
Page seeded by OCA on Mon Feb 16 14:09:00 2009
Categories: Homo sapiens | Bossi, G. | Boultier, J M. | Cerundolo, V. | Chen, J L. | Choi, E M.L. | Dunbar, P R. | Esnouf, R M. | Griffiths, G. | Held, G. | Jackobsen, B K. | Jones, E Y. | Lissin, N M. | Merwe, P A.Van Der. | Renner, C. | Rizkallah, P. | Sami, M. | Sewell, A. | Stewart-Jones, G. | Wooldridge, L. | Immune system/receptor | Immunoglobulin domain | Receptor | Superagonist peptide t-cell vaccine | T-cell | Transmembrane